Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Osaka Group Proposes Transferring Pharmaceutical Process Approval Authority To Prefecture Government

This article was originally published in PharmAsia News

Executive Summary

Osaka Bio Headquarters issued a proposal Nov. 11 asking the state government to transfer its pharmaceutical manufacturing review and approval authority to the prefecture government. The group is composed of the Osaka prefecture government, the Osaka Chamber of Commerce and Hankyo Railway, and has established measures to promote Osaka as a biology and pharmaceutical center. To speed up the drug development and commercialization process, the group suggests the Osaka prefecture government should review and approve process changes such as adding production lines and conducting good manufacturing practice inspections. The proposal will be presented to the Cabinet office Nov. 13. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts